KINNEVIK INVESTS USD 60 MILLION IN TRANSCARENT – THE FIRST COMPREHENSIVE HEALTH AND CARE EXPERIENCE COMPANY FOR SELF-INSURED EMPLOYERS
Kinnevik AB (publ) ("Kinnevik”) today announced that it has invested USD 60m in Transcarent, a new and different health and care experience company for employees of self-insured employers and their families. Transcarent is led by Glen Tullman, the Founder and former Executive Chairman and Chief Executive Officer of Livongo, one of Kinnevik’s first healthcare investments.
For further information, visit www.kinnevik.com or contact:
Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com
Email: press@kinnevik.com
Kinnevik’s ambition is to be Europe’s leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthtech, consumer services, foodtech and fintech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe, with a focus on the Nordics, and in the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.